Go to content
UR Home

The antiparkinsonian actions and pharmacokinetics of transdermal (+)-4-propyl-9-hydroxynaphthoxazine (+PHNO): preliminary results

URN to cite this document:
DOI to cite this document:
Coleman, R. J. ; Lange, Klaus W. ; Quinn, N. P. ; Loper, A. E. ; Bondi, J. V. ; Hichens, M. ; Stahl, S. M. ; Marsden, C. D.
Date of publication of this fulltext: 20 Jul 2012 13:25


(+)-4-Propyl-9-hydroxynaphthoxazine (+PHNO) is a potent dopamine agonist that has been administered transdermally to four patients with Parkinson's disease and "on-off" fluctuations. Skin patches of increasing size were used to treat these patients, who also received infrequent doses of oral levodopa if required. The effect of +PHNO was measured as an increased duration of action of individual ...


Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: datahub@ur.de
0941 943 -5707

Contact persons